278 related articles for article (PubMed ID: 14761193)
21. A selective human H(4)-receptor agonist: (-)-2-cyano-1-methyl-3-[(2R,5R)-5- [1H-imidazol-4(5)-yl]tetrahydrofuran-2-y] methylguanidine.
Hashimoto T; Harusawa S; Araki L; Zuiderveld OP; Smit MJ; Imazu T; Takashima S; Yamamoto Y; Sakamoto Y; Kurihara T; Leurs R; Bakker RA; Yamatodani A
J Med Chem; 2003 Jul; 46(14):3162-5. PubMed ID: 12825954
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
[TBL] [Abstract][Full Text] [Related]
23. Modification of the estrogenic properties of diphenols by the incorporation of ferrocene. Generation of antiproliferative effects in vitro.
Vessières A; Top S; Pigeon P; Hillard E; Boubeker L; Spera D; Jaouen G
J Med Chem; 2005 Jun; 48(12):3937-40. PubMed ID: 15943467
[TBL] [Abstract][Full Text] [Related]
24. Potential use of an estrogen-glucocorticoid receptor chimera as a drug screen for tissue selective estrogenic activity.
Maru BS; Tobias JH; Rivers C; Caunt CJ; Norman MR; McArdle CA
Bone; 2009 Jan; 44(1):102-12. PubMed ID: 18976723
[TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
Gougelet A; Bouclier C; Marsaud V; Maillard S; Mueller SO; Korach KS; Renoir JM
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):71-81. PubMed ID: 15862952
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, structural characterization and in vitro cytotoxicity and anti-bacterial activity of some copper(I) complexes with N,N'-disubstituted thioureas.
Rauf MK; Imtiaz-ud-Din ; Badshah A; Gielen M; Ebihara M; Vos Dd; Ahmed S
J Inorg Biochem; 2009 Aug; 103(8):1135-44. PubMed ID: 19570580
[TBL] [Abstract][Full Text] [Related]
27. Prenylation inhibitors stimulate both estrogen receptor alpha transcriptional activity through AF-1 and AF-2 and estrogen receptor beta transcriptional activity.
Cestac P; Sarrabayrouse G; Médale-Giamarchi C; Rochaix P; Balaguer P; Favre G; Faye JC; Doisneau-Sixou S
Breast Cancer Res; 2005; 7(1):R60-70. PubMed ID: 15642170
[TBL] [Abstract][Full Text] [Related]
28. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
29. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
Yoo J; Dence CS; Sharp TL; Katzenellenbogen JA; Welch MJ
J Med Chem; 2005 Oct; 48(20):6366-78. PubMed ID: 16190762
[TBL] [Abstract][Full Text] [Related]
30. Neighboring group participation. Part 16. Stereoselective synthesis and receptor-binding examination of the four stereoisomers of 16-bromomethyl-3,17-estradiols.
Szájli A; Wölfling J; Mernyák E; Minorics R; Márki A; Falkay G; Schneider G
Steroids; 2006 Feb; 71(2):141-53. PubMed ID: 16297947
[TBL] [Abstract][Full Text] [Related]
31. Effects of environmental estrogenic chemicals on AP1 mediated transcription with estrogen receptors alpha and beta.
Fujimoto N; Kitamura S
J Steroid Biochem Mol Biol; 2004 Jan; 88(1):53-9. PubMed ID: 15026083
[TBL] [Abstract][Full Text] [Related]
32. Breaking the mirror: pH-controlled chirality generation from a meso ligand to a racemic ligand.
Zhang L; Zhang J; Li ZJ; Qin YY; Lin QP; Yao YG
Chemistry; 2009; 15(4):989-1000. PubMed ID: 19086049
[TBL] [Abstract][Full Text] [Related]
33. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents.
Prasad V; Birzin ET; McVaugh CT; Van Rijn RD; Rohrer SP; Chicchi G; Underwood DJ; Thornton ER; Smith AB; Hirschmann R
J Med Chem; 2003 May; 46(10):1858-69. PubMed ID: 12723949
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of imidazoline and imidazo[2,1-c][1,2,4]triazole aryl derivatives containing the methylthio group as possible antibacterial agents.
Sztanke K; Pasternak K; Sidor-Wójtowicz A; Truchlińska J; Jóźwiak K
Bioorg Med Chem; 2006 Jun; 14(11):3635-42. PubMed ID: 16455261
[TBL] [Abstract][Full Text] [Related]
35. Stereocontrolled synthesis of four diastereomeric C-aryl manno- and talofuranosides.
Ravarino E; Jana SK; Fröhlich R; Holl R
Carbohydr Res; 2012 Nov; 361():162-9. PubMed ID: 23026710
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and structure-activity relationships of ferrocenyl tamoxifen derivatives with modified side chains.
Nguyen A; Top S; Pigeon P; Vessières A; Hillard EA; Plamont MA; Huché M; Rigamonti C; Jaouen G
Chemistry; 2009; 15(3):684-96. PubMed ID: 19053086
[TBL] [Abstract][Full Text] [Related]
37. 1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.
Schertl S; Hartmann RW; Batzl-Hartmann C; Schlemmer R; Spruss T; Bernhardt G; Gust R; Schönenberger H
Arch Pharm (Weinheim); 2001 Apr; 334(4):125-37. PubMed ID: 11382148
[TBL] [Abstract][Full Text] [Related]
38. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
Liu Z; Shi HY; Nawaz Z; Zhang M
Cancer Lett; 2004 Jun; 209(1):55-65. PubMed ID: 15145521
[TBL] [Abstract][Full Text] [Related]
39. Novel estrogen receptor ligands based on an anthranylaldoxime structure: role of the phenol-type pseudocycle in the binding process.
Minutolo F; Antonello M; Bertini S; Ortore G; Placanica G; Rapposelli S; Sheng S; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA; Macchia M
J Med Chem; 2003 Sep; 46(19):4032-42. PubMed ID: 12954056
[TBL] [Abstract][Full Text] [Related]
40. Bis(mu-oxo)dicopper(III) complexes of a homologous series of simple peralkylated 1,2-diamines: steric modulation of structure, stability, and reactivity.
Cole AP; Mahadevan V; Mirica LM; Ottenwaelder X; Stack TD
Inorg Chem; 2005 Oct; 44(21):7345-64. PubMed ID: 16212361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
